Lightnews — Scholar-powered news

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · 25d

See you there!

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 25

Really? Another one? There's been like 8 versions of this same manuscript published in CID over the last 1-2 years. Same population (2019- April 2022). Gimme a break.

This isn't applicable in 2025.

1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 25

In fact, the latest that patients were included was Apr 2022 -- their "lit review went through Dec 2023"

1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 25

Not only different variants, but incredibly different levels of seroprevalence in the population.

This seems to be the same population that Gilead has re-statistically analyzed over and over again in different ways.

Mozzafari has about 4 manuscripts doing this exact same thing in different pops

1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 25

Why would patients 2019 through 2023 be put in the same SRMA?

2

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 17

Listeria has entered the chat

1 1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 14

Amox +/- probenecid seems to work well, so yes?

1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 13

Is that the endotracheal aspirate reminder beep again?!

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 13

The CRP is up 0.8 from yesterday!

1 1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 13

Nobody has yet to provide me with any reason why we can’t study 2-3d of an oral cephalosporin rather than this continued narrative that we have no options.

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 13

The Vikings shoes 😻😻

1 1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 13

Just like all the “aspiration events” that happen on the floor always seem to end in pneumonia. Immediately. Every time.

1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Aug 13

I am presenting with @bwtrautner.bsky.social on UTIs on Wednesday 😅

1 8

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Jul 2

How about linezolid?

1 2

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · May 31

I wonder why that could possibly be…….

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · May 3

Hi there. I was disappointed in the misinterpretation of our remdesivir study on this episode. Let me know if you’d like to discuss.

Reposted by Zack (Snacks) Nelson, PharmD, MPH

CIDRAP @cidrap.bsky.social · Apr 28

#COVID patients who don't receive remdesivir not more likely to die, data suggest

Models found no difference in all-cause death rates, 30-day hospital readmissions, or length of stay before and after restrictions were put into place.

www.cidrap.umn.edu/c...

6 10

Reposted by Zack (Snacks) Nelson, PharmD, MPH

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Apr 26

In CID: Our real world study is the 1st (to our knowledge) to detail widespread restriction of remdesivir with patients that represent present-day epidemiology in the era of near universal SARS-CoV-2 seropositivity.

#IDSky
#MedSky
@ebhirsch.bsky.social

academic.oup.com/cid/advance-...

Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 Seropositivity

AbstractBackground. There is limited data to support routine remdesivir use in the contemporary era of SARS-CoV-2 with widespread seropositivity.Methods. A

academic.oup.com

4 4 18

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Apr 27

Yes! Of course. DM me if you have any other questions! Happy to share our experience.

1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Apr 26

Had to be immunocompromised due to medication, condition, or pregnancy on supplemental oxygen to be eligible to receive the drug without ID consult.

1 1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Apr 26

CC:
@absteward.bsky.social
@cidjournal.bsky.social

1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Apr 26

In CID: Our real world study is the 1st (to our knowledge) to detail widespread restriction of remdesivir with patients that represent present-day epidemiology in the era of near universal SARS-CoV-2 seropositivity.

#IDSky
#MedSky
@ebhirsch.bsky.social

academic.oup.com/cid/advance-...

Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 Seropositivity

AbstractBackground. There is limited data to support routine remdesivir use in the contemporary era of SARS-CoV-2 with widespread seropositivity.Methods. A

academic.oup.com

4 4 18

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Apr 15

Anyone want to study more than a single dose of a beta lactam for NG with me? :)

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Apr 11

Did WikiGuidelines come up?

1

Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · Apr 9

Cloceba too in the same session